The research with psychedelic drugs can change our understanding of the human mind. Watch our video report from the International Interdisciplinary Conference on Psychedelic Research! Watch some of the key presentations too!
Leading national and international experts and activists discussed barriers and opportunities at the first conference on medical cannabis in Hungary.
Medical cannabis activists formed an alliance with a political party, in order to contest the parliamentary elections in Serbia. Read Irena Molnar’s report from Belgrade, and watch the video!
A surprise decision from the otherwise super-conservative Polish government: it improves access to cannabis for medical purposes.
Progress should not cause us to lose sight of our core values. Please watch our video and read our article about the 2015 International Drug Policy Reform Conference, which was held in Washington DC between 18-21 November!
A speech delivered by the Director of the Drug Policy Alliance at the opening session of the International Drug Policy Reform Conference in Washington DC.
Scientists at the University of Debrecen, Hungary, are aiming to work on cutting-edge research to study how endogenous DMT, occurring naturally in the body, may be useful to modern medicine, particularly by protecting brain cells in the stage of clinical death.
The Hungarian government banned 42 new psychoactive substances this year – but some of them are not new at all, for example Ibogaine. The Hungarian Civil Liberties Union is suing a government agency for not providing access to the assessment reports on the risks of these drugs.
Films about drug policy reform from New Zealand to Europe, video advocacy trainings, conferences, reports and campaigns about harm reduction, consultation with decision makers at the national and European level – the Drugreporter Team had a very active year in 2014. Please read & download our colorful 2014 Annual Report and learn more!
Regulated medical marijuana has come out of the blue as a feasible alternative in Serbia, where overwhelming public support favours regulating hemp-based medicines. The promised draft law is still awaited, however, and will then require the approval of the national parliament.